Institutional & Family Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1
| Closed | -$962 | – | 771 |
|
|
2024
Q1 | $962 | Hold |
1
| – | – | ﹤0.01% | 640 |
|
|
2023
Q4 | $878 | Hold |
1
| – | – | ﹤0.01% | 622 |
|
|
2023
Q3 | $823 | Hold |
1
| – | – | ﹤0.01% | 626 |
|
|
2023
Q2 | $719 | Hold |
1
| – | – | ﹤0.01% | 650 |
|
|
2023
Q1 | $822 | Hold |
1
| – | – | ﹤0.01% | 645 |
|
|
2022
Q4 | $721 | Hold |
1
| – | – | ﹤0.01% | 630 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 668 |
|
|
2022
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 686 |
|
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 721 |
|
|
2021
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 752 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 866 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 910 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 984 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 913 |
|
|
2020
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 803 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 797 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 885 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 881 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 873 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 867 |
|
|
2019
Q1 | $0 | Sell |
1
-48
| -98% | – | ﹤0.01% | 868 |
|
|
2018
Q4 | $18K | Sell |
49
-4
| -8% | -$1.47K | ﹤0.01% | 418 |
|
|
2018
Q3 | $21K | Hold |
53
| – | – | ﹤0.01% | 433 |
|
|
2018
Q2 | $18K | Hold |
53
| – | – | ﹤0.01% | 450 |
|
|
2018
Q1 | $18K | Buy |
+53
| New | +$18K | ﹤0.01% | 428 |
|